Oxidative stress and neurodegenerative disorders

Journal of Biomedical Science

Volumn 5, Issue 6, 1998, Pages 401-414

  Sun, Albert Y ^a   Chen, Yong Mei ^a  

^a University of Missouri   (United States)

Author keywords

Antioxidants; Apoptosis; Excitotoxicity; Hydroxyl radical; Neurodegenerative disorders; Oxidative stress; Peroxynitrite; Polyphenols; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMYLOID PROTEIN; ANTIOXIDANT; APOLIPOPROTEIN E; ASCORBIC ACID; CATALASE; CATECHIN; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IRON CHELATING AGENT; POLYPHENOL; PROBUCOL; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SELEGILINE; SUPEROXIDE DISMUTASE;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; CELL PROTECTION; DIET SUPPLEMENTATION; DRUG MECHANISM; HUMAN; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVIEW; STROKE;

ANIMALIA;

EID: 0031773098     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02255928     Document Type: Review

References (196)

1. Allsopp TE, Wyatt S, Peterson HF, Davies AM. The proiooncogene Bcl 2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis Cell 73:295-307;1993.
2. Alzheimer A. Über eine eigenartige Erkrankung der Himrinde. All Z Psychiatr 64:146-148;1907.
3. Ames BN, Shigenaga MK, Hagen TM. Oxidants. antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922;1993.
4. Arai H, Higuchi S, Sasaki H. ApoE genotyping and cerebrospinal fluid tau protein: Implication for the clinical diagnosis of Alzheimer's disease. Gerontology-13 (suppl 1):2-10;1997.
5. Bartlett D, Church DF, Bounds PL, Koppenol WH. The kinetics of the oxidation of L-ascorbic acid by peroxynitrite. Free Radic Biol Med 18:85-92;1995.
6. Beal MF. Aging, energy and oxidative stress in neurodegeneratue diseases. Neural 38:357-366;1995
7. Beckman JS. Peroxynitrite versus hydroxyl radical: The role of nitric oxide in superoxidedependent cerebral injury. Ann NY Acad Sci 738:69-75;1994.
8. Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite. Implication for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 87:1620-1624;1990.
9. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77:817-827;1994.
10. Behl C, Sagara Y. Mechanism of amyloid beta protein-induced neuronal cell death: Current concepts and future perspectives. J Neural Transm 49 (suppl):125-134;1997.
11. Bennister JV, Ballanate P, Sema MC, Thomalley PJ, Rossi F. An EPR study of the production of Superoxide radicals by neutrophil NADPH oxidase. FEBS Lett 145:323-326; 1982.
12. Borovic S, Zarkovic N, Wildburger R, Tatzber F, Jurin M. Posttraumatic differences in the titer of autoantibodies against oxidized low density lipoproteins (OLDL) in the sera of patients with bone fracture and traumatic brain injury. Periodicum Biol 97:209-293;1995.
13. Borovitskaya AE, Evtushenko VI, Sabol SL. 1 Gamma radiation-induced cell death in the fetal rat brain possesses molecular characteristics of apoptosis and is associated with specific messenger RNA elevation. Mol Brain Res 35: 19-30;1996.
14. Boveries A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbasic oxygen. Biochem J 134:707-716;1973.
15. Brawn K, Fridovich I. DNA strand scission by enzymicaily generated oxygen radicals. Arch Biochem Biophys 206:414-419;1981.
16. Brierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP. Neocortical neurofibrillary tangles correlate with dementia seventy in Alzheimer's disease. Arch Neurol 52:81-88;1995.
17. Brown GC, Nitric oxide regulates mitochondrial respiration and cell function by inhibitory cytochrome oxidase. FEBS Lett 369:136-139; 1995.
18. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7-10;1994.
19. Chanvitayapongs S, Draczynska-Lusiak B, Sun AY. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 8:1499-1502;1997.
20. Chen YM. Excitotoxicity in neurodegenerative Disorders, PhD thesis, University of Missouri-Columbia, 1998.
21. Chen YM, Sun AY. Activation of transcription factor AP-1 by extracellular ATP in PC12 cells. Neurochem Res 23:543-550;1998.
22. Cheng Y. Mechanisms of KA-induced neuronal excitotoxicity, PhD Thesis, pp 178; University of Missouri, Columbia. MO; 1993.
23. Cheng Y, Chen M, Wixom P. Sun AY. Extra-cellular ATP may induce neuronal degeneration by a free-radical mechanism. Ann NY Acad Sci 738:431-435;1994.
24. Cheng Y, Chen M, James-Kracke MR. Wixom P. Sun AY. Enhanced lipid peroxidation by extracellular ATP in PC12 cells. Neurochem Res 21:27-33;1996.
25. Chiueh CC, Wu RM, Mohanakumar KP, Sternberger LM, Krishna G, Obata T, Murphy DL. In vivo generation of hydroxyl radical and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann NY Acad Sci 738:25-36; 1994.
26. Choi DW. Excitotoxic cell death. J Neurobiol 23:1261-1276;1992.
27. Choi DW. Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18:58-60;1995.
28. Chung MI, Teng CM, Cheng KL, Ko FN, Lin CN. An anti-platelet principle of Veratrum formosanum. Planta Med 58:274-276;1992.
29. Cohen G, Farooqui R. Kesler N. Parkinson's disease: A new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci USA 94:4890-4894;1997.
30. Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ. The regional distribution of iron in aging and Alzheimer's disease. J Neurosci Res 31:327;1992.
31. Connor JR, Menzies SL, St Mann SM, Murison EJ. A histochemical study of iron, transferrin and ferrtin in Alzheimer's disease brain. J Neurosci Res 31:75-83;1992.
32. Corder EH, Soundes AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923;1993.
33. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695;1993.
34. Crumrine RC, Thomas AL, Morgan PF. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab 14:887-891;1994.
35. Davies KJ. Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem 262:9895-9901;1987.
36. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88:6368-6374;1991.
37. Deckwerth TL, Johnson EM, Jr. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol 123:1207-1222;1993.
38. Desole MS, Sciola L, Delogue MR, Siacana S, Migheli R, Miele E. Role of oxidative stress in the manganese and l-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced apoptosis in PC 12 cells. Neurochem Int 31:169-176;1997.
39. Dexter DT, Carter CJ, Wekks FR. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52:381-389; 1989.
40. Dexter DT, Jenner P, Schapira AH, Marsden CD. Alterations m level of iron, femtin, and other trace metals m neuronal degenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 32 (suppl S9):4-100;1992.
41. Dexter DT, Sian J, Rose S, et al. indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35:38-44;1994.
42. Dickson DW, Lee SC, Mattiace L, Yen SHC, Brosnan C. Microglia and cytokines in neurological disease with special reference to AIDS and Alzheimer's disease. Glia 7:75-83;1993.
43. Draczynska-Lusiak B, Doung A, Sun A. Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer's disease. Mol Chem Neuropathol 33:139-148;1998.
44. Draczynska-Lusiak B, Chen YM, Sun AY. Oxidized lipoproteins activate NT-κB binding activity and apoptosis in PC12 cells. Neuroreport 9:527-532;1998.
45. +: Implications for neurodegeneration. J Neurochem 63:584-591; 1994.
46. 2. Atherosclerosis 132:165-176;1997.
47. France-Lanord V, Brugg B, Michel PP, Agid Y, Ruberg M. Mitochondrial free radical signal in ceramide-dependent apoptosis: A putative mechanism for neuronal death in Parkinson's disease. J Neurochem 69:1612-1621;1997.
48. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human low density lipoprotein oxidation by resveratrol. Lancet 341:1103-1104; 1993.
49. Freeman BA, Crapo JD. Free radical and tissue injury. Lab Invest 47:412-426;1982.
50. Fridovich I. Superoxide dismutase. Science 44: 147-159;1975.
51. Gasic GP, Hollmann M. Molecular neurobiology of glutamate receptors. Annu Rev Physiol 54:507-536;1992.
52. Gerlach M, Youdim MBH, Reiderer P. Pharmacology of seligeline. Neurology 47 (suppl 3): S137-143;1996.
53. Glenner GG, Wong CN. Alzheimer's disease: Initial report of the purification and characterization on a novel cerebrovascular amyloid protein. Biochem Biophys Res Comman 120: 885-890;1984.
54. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated LDL, producing massive cholesterol deposition. Proc Natl Acad Sci USA 96:333-337;1979.
55. Goldstein JL, Basu SK, Brown MS. Receptor mediated endocytosis of low density lipoprotein in cultured cells. Methods Enzymol 98: 241-261;1983.
56. Good PF, Perl D, Bigrer LM, Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe study. Ann Neurol 31:286-292;1992.
57. Gorman AM, McGowan A, O'Neill C, Cotter T. Oxidative stress and apoptosis in neurodegeneration. J Neurol Sci 139 (suppl):45-52; 1996.
58. Graham DG. Oxidative pathway for catecholamines in the genesis of neuromelanin and cytotoxic qumones. Mol Pharmacol 14:633-643;1978.
59. Guillaume D, Bertrand P, Dea D, Davignon J. Poirier J. Apolipoprotein E and low-density lipoprotein binding and intemalization in primary culture of rat astrocytes: Isoform specific alterations. J Neurochem 66:2410-2418;1997.
60. Gunter TE, Gunter KK, Shen SS, Gavin CE. Mitochondrial calcium transport: Physiological and pathological relevance. Am J Physiol 267C:313-339;1994.
61. Haas C, Koo EH, Mellon A, Selkoe DJ. Targeting of cell surface β-amyloid precursor protein to lysosomes: Altername processing into amyloid bearing fragments. Nature 357:500-503; 1992.
62. Haas C, Schlossmacher MG. Hung AY, VigoPelbray C, Mellon A, Ostaszewski B, Liebergurg I, Koo E, Schenk D, Teplow D, Selkoe DJ. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325;1992.
63. Halliwell B. Reactive oxygen species in living systems: Source, biochemistry, and role in human disease. Am J Med 91:14S-22S;1991.
64. Halliwell B. Free radicals and antioxidants: A personal view. Nutr Rev 52:253-265;1995.
65. Halliwell B, Gutteridge JM. Oxygen radicals and the nervous system. Trends Neurosci 6: 22-26;1985.
66. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186:1-85; 1990.
67. Ham J, Bahyi C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939;1995.
68. Healing G, Gower J, Fuller B, Green C. Intraceuular iron redistribution. An important determinant of reperfusion damage to rabbit kidneys. Biochem Pharmacol 39:1239-1245; 1990.
69. Hensley K, Camey JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Natl Acad Sci USA 92:4402-4406;1994.
70. Hertel C, Terzi E, Hauser N, Jakob Rome R, Seelig J, Kemp JA. Inibition of the electrostatic interaction between β-amyloid peptide and membranes prevents β-amyloid-induced toxicity. Proc Natl Acad Sci USA 94:9412-9416; 1997.
71. Hirsch EC, Grabiel AM, Agid Y, Melanised dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334:345-348;1988.
72. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 17:31-108; 1994.
73. Hope BT, Kelz MB, Duman RS, Nestler EJ. Chronic electroconvulsive seizure (ECS) treatment results in expression of long-lasting AP-1 complex in brain with altered composition and characteristics. J Neurosci 14:4318-1328: 1994.
74. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132-139;1997.
75. Iwata M, Mukai M, Nakai Y, Iseki R. Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J Immunol 149:3302-3308;1992.
76. Jacobson MG, Burne JF, Raff MC. Programmed cell death and Bcl-2 protection in the absence of nucleus. EMBO J 13:1899-1910; 1994.
77. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Bescher WW, Fong HHS, Farnswoth NR, Kinghom AD, Mehti GR, Moon RC, Pezzuto JM. Cancer preventive activity of resveratrol. a natural product derived from grape. Science 275:218-220;1997.
78. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (6 suppl 3):S161-S170;1996.
79. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 135: 309-320;1989.
80. Kaminska B. Filipkowski RK, Zurkoska G, Lason W, Przenlocki R, Kaczmareki L. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death. Eur J Neurosci 6:1558-1566;1994.
81. Kapiotis S, Hermann M, Held I, Seelos C, Ehringer IT, Gmeiner BMK. Genistein, the dietary-derived angiotenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 17:2868-2874;1997
82. Kasof GM, Mandelzys A, Maika SD, Hammer RE, Cuirau T, Morgan JC. Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats. J Neurosci 15:4238-4247;1995.
83. Keller N, Kindy MS, Holtsberg FW, St. Clair DK, Yen H-C, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP. Mitochondrial manganese Superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: Suppression of peroxynitrite production, lipid peroxidation, and mitochondnal dysfunction. J Neurosci 18:687-697;1998.
84. Kim-Han J, Sun AY. Protection of PC 12 cells by glutathione peroxidase in L-DOPA induced cytotoxicity. Free Radic Biol Med 25:512-518; 1998.
85. Kluck RM, Bossy-Wetzel E, Green DR. Newmeyer DD. The release of cytochrome C from mitochondria: A primary site for the Bcl-2 regulation of apoptosis. Science 275:1132-1136; 1997.
86. Kong J, Lemaire HG. Unterbeck A et al: The precursor of Alzheimer's disease amyloid A4 resembles a cell surface receptor. Nature 325-733-736;1987.
87. Kroemer G. Mitochondrial implication in apoptosis - towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ 4: 443-456;1997.
88. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 18:44-51;1997.
89. Kumura E, Yoshimine T, Iwatsuki KI, Yamenaka K, Taacka S, Hayakawa T, Shiza T, Kosaka H. Generation of nitric oxide and Superoxide dunng reperfusion after focal cerebral ischemia in rats. Am J Physiol 270: C748-C752;1996.
90. Ladecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132-139;1997.
91. LaDu MJ, Falduto MT, Menelli AM, Reardon CA, Getz GS, Frail DE. Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 269:23403-23406;1994.
92. LaDu MJ, Luken JR, Reardon CA, Getz GS. Association of human, rat and rabbit apolipoprotein E with β-amyloid. J Neurosci Res 49: 9-18;1997.
93. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent Superoxide production and neurotoxicity. Nature 364:535-537; 1993.
94. Lai CT, Yu PH. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells. Toxicol Appl Pharmacol 142:186-191;1997.
95. Lerma J, Morales M. Vicente MA, Herreras O. Glutamate receptors of the kainate type and synaptic transmission. Trends Neurosci 20:9-12;1997.
96. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl J Med 330:613-622;1994.
97. Liu LF, Brachova L, Civin WH, Rogers J. Inflammation, A-beta deposition and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 55:1083-1088; 1996.
98. Liu X, Kim CM, Yang J, Jemmerson R, Wang X. Induction of apoptosis program in cell-free extracts: Requirement for dATP and cytochromeC. Cell 86:147-157;1996.
99. Lockhart BP, Bemcourt C, Junien JL, Privat A. Inhibitors of free radical formation fail to attenuate direct b-amyloid peptide-mediated neurotoxicity in rat hippocampal cultures. J Neurosci Res 39:494-505;1994.
100. Loiacono RE, Bean PM. Hippocampal lesions induced by microinjection of the nitric oxide donor nitropmsside. Eur J Pharmacol 216:331-333;1992.
101. Lovestone S, Anderton BH, Hartley C, Jensen TG, Horgeusen AL. The intracellular fate of apolipoprotein E is tau dependent and apo allele-specific. Neuroreport 7:1005-1008;1996.
102. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch Ophthalmol 58:193-201;1997.
103. Lustig HS, von Brauchitsch KL, Chan J, Greenberg DA. Ethanol and excitotoxicity in cultured cortical neurons: Differential sensitivity of N-methyk-D-aspartate and sodium nitroprusside toxicity. J Neurochem 59: 2193-2200;1992.
104. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal. an aldehydic product of Hpid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 68:255-264;1997.
105. Markesberry WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radie Biol Med 23:134-147;1997.
106. Mattson MP, Tomaselli KJ, Tydel RE. Calcium destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 621:35-49; 1993.
107. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65:1740-1751;1995.
108. !08 McBain CJ, Mayer ML. N-methyk-D-aspartic acid receptor structure and function. Physiol Rev 74:723-760;1994.
109. McIntosh LF, Trush MA, Troncoso JC. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated process. Free Radic Biol Med 23:183-190;1997.
110. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, Shoffner JM, Wallace DC, Beal MF. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neural 34:609-616; 1993.
111. Meyer AS, Heinonen M, Frankel EN. Antioxidant interaction of catechin, cyanidin, caffeic acid, quercatin and ellagic acid on human LDL oxidation. Food Chem 61:71-75;1998.
112. Minotti G, Aust SD. Redoxcycling of iron and lipid peroxidation. Lipids 27:219-226; 1992.
113. Mitchell IJ, Lawson S, Moser B, Laidlaw SM, Copper AJ, Walkinshaw G, Waters CM. Glutamate induced apoptosis results in a loss of striatal neurons in the Parkinsonian rat. Neuroscience 63:1-5;1994.
114. Mori H, Mishma M. Structure and function of the NMDA receptor channel. Neuropharmacology 34:1219-1237;1995.
115. Muir KW. Lees KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-513;1995.
116. Multhaup G, Rappert T, Schlicksupp A, Hesse L, Beher D, Masters CC, Beyrenther K. Reactive oxygen species and Alzheimer's disease. Biochem Pharmacol 54:533-539;1997.
117. Nakano M, Cenzil F, Mizuno R, Gotoh S. Age-related changes in the lipofuscin accumulation of brain and heart. Gerontology 41 (suppl 2):69-79;1995.
118. Nappi AJ, Vass E. Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione. cysteine, ascorbic acid and selective catechols. Biochim Bicphys Cata 1336:295-301;1997.
119. Nowicki JP, Duval D, Poignet H, Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 204:339-340;1991.
120. Olanow CW. A radical hypothesis for neurodegeneration. Trends Neurosci 16:439-444; 1993.
121. O'Neill LAJ, Kaltschmidt C. NF-κB: A crucial transcription factor for glial and neuronal cell formation. Trends Neurosci 20:252-258; 1997.
122. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO, Requirement for Superoxide in excitotoxic cell death. Neuron 16:345-355; 1996.
123. Pennypacker KR, Hong J. McMiliian MK. Pharmacological regulation of AP-1 transcription factor DNA binding activity. FA-SEB J 8:475-478;1994.
124. Petit PX, Susin SA, Zamzami N, Mignotte B, Kroemer G. Mitochondria and programmed cell death: Back to the future. FEBS Lett 396: 7-13;1996.
125. Pike CJ, Ramezan-Arab N, Cotman CW. βAmyloid neurotoxicity in vitro: Evidence of oxidative stress but not protection by antioxidants. J Neurochem 69:1601-1611;1997.
126. Pitas RE, Bayles JK, Lee SH, Foss D, Mahley RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917:148-161;1984.
127. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH. Lipoproteins and their receptors in the central nervous system. J Biol Chem 262: 14352-14360;1987.
128. Pluta R, Barcikowska M, Debicki G, Ryba M, Januszewski S. Changes in amyloid precursor proteins and apolipoprotein E immunoreactivity following ischemic injury m rat with long-term survival: Influence of idebenone treatment. Neurosci Lett 232:95-98;1997.
129. Poirier J. Apolipoprotein E in the brain and its role in Alzheimer's disease. J Psychiat Neurosci 21:128-134;1996.
130. Pollard H, Cament-Marlangue C, Cantagrel S, Represa A, Robain O, Moreau J, Ben-Ari Y. Kainate induced apoptosis cell death in hippocampal neurons. Neuroscience 63:7-18;1994.
131. Radi R, Rodriguez M. Castro L, Teilen RC. Inhibition of mitochondrial electron transport by peroxynilrite. Arch Biochem Biophys 308:89-95;1994
132. Riedel G. Function of metabotropic glutamate receptors in learning and memory. Trends Neurosci 19:219-224;1996.
133. Riederer P, Sofic E, Rausch W. Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brain. J Neurochem 52:515-521;1989.
134. Rothman RJ, Serron: A, Farber JI. Cellular pool of transient feme iron, chelatable by deferoxamine and distinct from femtin. that is involved in oxidative cell injury. Mol Pharmacol 42:703-710;1992.
135. Sagara Y, Dargasch R, Klier FG, Schuhen D, Behl C. Increased antioxidant enzymes activity in amyloid βprotein-resistant cells. J Neurosci 16:497-505;1996.
136. Sakurai T, Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Leu 236:406-410;1988.
137. Sandoval M, Zhang XJ, Liu X, Mannick EE, Clark DA, Miller MJS. Peroxynitrite-induced apoptosis in T84 and RAW 264.7 cells: Attenuation by L-ascorbic acid. Free Radic Biol Med 22:489-495;1997.
138. Schapira AHV. Evidence for mitochondrial disfunction in Parkinson's disease - a critical appraisal. Mov Disord 9:125-138;1994.
139. Schulz JB, Matthews RT, Klockgether T, Dichgans J, Beal MF. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem 174:193-197;1997.
140. Schulze-Osthoff K, Los M, Bauerle PA. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem Pharmacol 50:735-741;1995.
141. Sessa WC, Hecker M, Mitchell JA, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-Glutamine inhibits the generation of L-arginine by cultured endothelial cells. Proc Natl Acad Sci USA 87: 8607-8611;1990.
142. Seubert P, Urgo-Pelfrey C, Esch F, et al. Isolation and quantitation of soluble Alzheimer's β-peptide from biological fluids. Nature 359: 325-327;1992.
143. Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol 247(suppl 2):S3-S14;1997.
144. Shinobu LA, Beal MF. The role of oxidative processes and metal ions in aging and Alzheimer's disease. In: Connor JR. ed. Metals and Oxidative Damage in Neurological Disorders. New York, Plenum Press. 237-275; 1997.
145. Shohami E, Beit-Yannai E, Horowitz M, Kohen R. Oxidative stress in closed-head injury. Brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood FIowMetab 17:1007-1019;1997.
146. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83-106;1996.
147. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Mias GG, Schilling K. Robertson LM, Curran T, Morgan J. Continuousc-fos expression precedes programmed cell death in vivo. Nature 363:166-169;1993.
148. Sohal RS, Agarwal S, Dubey A, Orr WC Protein oxidative damage is associated with life expectancy of house flies. Proc Natl Acad Sci USA 90:7255-7259;1993.
149. Spina MB, Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc Natl Acad Sci USA 86: 1398-1400;1989.
150. Stadtman ER Oxidation of free ammo acids and amino acid residues in proteins by radiolysis and by metal-cataiyzed reactions. Annu Rev Biochem 62:797-821, 1993.
151. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low density lipoprotein that increases its alherogenicin. N Engl J Med 320:915-924;1989.
152. Steller H. Mechanism and gene of cellular suicide. Science 267:1445-1449;1995.
153. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: High avidity binding 10 beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc Natl Acad Sci USA 90:1977-1981;1993.
154. Strittmatter WJ, Weisgraber KH, Huang DY. et al. Binding of human apohpoprotein E to synthetic amyloid beta peptides: Isoform specific effects and implication for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90:8098-8102;1993.
155. Strittmatter WJ, Wetsgraber KH, Goedert M, Sounder AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Han SH, Mulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD: Hypothesis: microtubule instability and paired filament formation in the Alzheimer's disease brain are related to apolipoprotein E genotype. Exp Neurol 125:163-171;1994.
156. Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169:1543-1555;1989.
157. Sucher NJ, Awobuluyi M, Choi YB, Lipton SA. NMDA receptors: from genes to channels. Trends Pharmacol Sci 17:348-355; 1996.
158. Sun AY, Chen YM. Extracellular ATP-induced apoptosis in PC12 cells: In Ehrlich Y, ed. Molecular and Cellular Mechanisms of Neuronal Plasticity: Basic and Clinical application. New York, Plenum Press, 1998.
159. Sun AY, Cheng Y, Bu Q, Oldfield F. The biochemical mechanism of the excitotoxicity of kainic acid. Free radical formation. Mol Chem Neuropathol 17:51-63;1992.
160. Sun AY, Yang WL, Kim HD. Free radical and lipid peroxidation in manganese-induced neuronal cell injury. Ann NY Acad Sci 679: 359-363;1993.
161. Sun AY, Chen YM, Lusiak B. The protective action of resveratral on apoptotic cell death induced by oxidized lipoproteins. In: Packard L, ed. Biological Oxidants and Antioxidants: Molecular Mechanism and Health Effect. Champaign, AOCS Press 210-222;1998.
162. Talley AK, Dewhurst S, Perry SW, Dollard SC, Gummulnon S, Fine SA, New D. Epstein LG, Gendelman HE, Gelbard HA. Tumor necrosis factor a-induced apoptosis in human neuronal cells. Protection by antioxidant N-acetyl cysteine and the genes bcl-2 and crm A. Mol Cell Biol 15:2359-2366;1995.
163. Terry RD, Masliah E, Hansen LA. Structural basis of the cognitive alterations in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL, eds. Alzheimer's Disease. New York, Raven Press, 179-196;1994.
164. Thompson CM, Markesberry WR, Ehmann WD, Mao YS, Vance DE. Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9:1-8;1988.
165. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462;1995.
166. Tong L, Perez-Polo JB. The transcription factor DNA binding activity in PC12 cells undergoing apoptosis after glucose deprivation. NeurosciLett 191:137-140;1995.
167. 2+ channels: A possible involvement of free radicals. J Neurochem 68:265-271;1997.
168. Van Dam PS, Bravenbaer B. Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci Res Commun 21:41-48; 1997.
169. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 76: 777-779;1994.
170. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: Isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radie Biol Med 23:302-313;1997.
171. Viana M, Barbas C, Banet B, Bonet MV, Castro M, Fraile MU, Herrera E. In vitro effect of a flavonoid-rich extract on LDL oxidation. Atherosclerosis 123:83-91;1996.
172. Vieira O, Escargueil-Blanc I, Lane I, Meilhae O, Basile JP, Laranjinhe J, Almeida L, Salvayre R, Negresalvayre A. Effect of dietary phenolic compounds on apoptosis of human cultured endothehal cells induced by oxidized LDL. BT J Pharmacol 123:565-573;1998.
173. Whittemore ER, Loo DT. Cotman CW. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuroreport 5:1485-1488;1994.
174. Wiseman H, Halliweil B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 313:17-29;1996.
175. Wismewski T, Lalowski M, Golabek A, Vogel T, Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet 345: 956-958;1995.
176. Wylhe AH, Kerr JF, Currie AR. Cell death: The significance of apoptosis. Intl Rev Cytol 68:251-306;1980.
177. Xiang J, Chao DT, Korsmeyer SJ. Baxinduced cell death may not require interleukin 1-beta-converting enzyme-like proteases. Proc Natl Acad Sci 29:2431-2439;1996.
178. Yang W, Sun AY. Paraquat-induced cell death m PC12 cells. Neurochem Res, in press.
179. Yang W, Sun AY. Paraquat-induced free radical reaction in mouse brain microsomes. Neurochem Res 23:47-53;1998.
180. Yang E, Zha J, Jockel J, Boisi LG, Thompson CB, Korsmeyer SJ. Bad. a heterodimeric partner for bcl-x1 and bcl-2 displace Bax and promotes cell death. Cell 80:285-291;1995.
181. Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16: 921-932;1996.
182. Yen SH, Liu WK, Hall FL, Yan SD, Stern D, Dickson DW. Alzheimer's neurofibrillary lesions: Molecular nature and potential roles of different compounds. Neurobiol Aging 16: 381-387;1995.
183. Yim HS, Rang SO, Hah YC, Chock PB, Yim MB. Free radicals generated during the glycation reaction of amino acid by methvlglyoxal. J Biol Chem 270:28228-28233;1995.
184. Yin D, Yeian X, Brunk UT. Test tube stimulated lipofiscinogenesis. Effect of oxidative stress on autophagocytotic degradation. Mech Ageing Dev 81:37-50;1995.
185. Yin D. Biochemical basis of lipofuscin, ceroid and age pigment-like fluorophores. Free Radie Biol Med 21:871-888;1996.
186. Yin XM, Oltval ZN, Korsmeyer SJ. BHa and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-323;1994.
187. Ying W. Deleterious network hypothesis of aging, Med Hypotheses 48:143-148;1997.
188. Yoshida T, Limmroth V, Irikura K, Moskowitz MA. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acethylcholine in pial vessels. J Cereb Blood Flow Metab 14:924-929;1994.
189. Youdium MBH, Ben-Shachar D, Yehuda S, Riederer P. The role of iron in the basal ganglion. Adv Neurol 53:155-162;1990.
190. Zeevalk GD, Bernard LP, Nicklas WJ. Role of oxidative stress and glutathione system in loss of dopamine neurons due to impairment of energy metabolism. J Neurochem 70: 1421-1430;1998.
191. Zembonicz AC, Vane JR. Induction of nitric oxide synthase activity by toxic shock syndrome ia a macrophage-monocytic cell line. Proc Natl Acad Sci: USA 89:2051-2055; 1992.
192. 2 generation. J Neurochem 67:1595-1606;1996.
193. Zhivotovsky B, Orrenius S, Brustugun OT, Doskeland SO. Injected cytochrome C induces apoptosis. Nature 39:449-450;1998.
194. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, Bredesen DE. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 90:4533-4537;1993.
195. Zhou Z, Smith JD, Greengard P, Gandy S. Alzheimer's amyloid-β peptide forms denaturant-resistant complex with type E3 but not type E4 isoforms of native apolipoprotein E. Mol Med 2:175-180;1996.
196. Zs-Nagy I, Steiber J, Janey F. Induction of age pigment accumulation in the brain cells of young male rats through iron-injection into the cerebrospinal fluid. Gerontology 41 (suppl 2):145-158;1995.